NBE Therapeutics has continuously built relationships and established value-adding partnerships with groups at top-tier academic institutions, like ETH-Zurich, Switzerland, The Scripps Research Institute, U.S., the University Clinics Basel, Switzerland, and the University of Erlangen, Germany, to mention a few. Together with these selected academic partners the in-house developed capabilities of the company can optimally be leveraged for achieving the development goals of NBE-Therapeutics.
In addition, NBE-Therapeutics has also entered into value-adding strategic collaborations with industry-partners, like Sotio a.s., Czech Republic, part of the PPF Group, that has more than € 20 billion capital under management.
- San Diego, USA, 2019-03-04 - NBE-Therapeutics invited to present at Terrapinn's Americas Antibody Congress
- San Diego, USA, 2018-12-11 - NBE-Therapeutics was invited to present at KNect365's 2018 Antibody Engineering & Therapeutics Conference
- Basel, 2018-11-15 - Dr. Anthony Tolcher joins the Scientific Advisory Board of NBE-Therapeutics